- Home
- BMEZ vs ARDX Comparison
BMEZ vs ARDX Comparison
Compare BMEZ & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEZ
- ARDX
- Stock Information
- Founded
- BMEZ N/A
- ARDX 2007
- Country
- BMEZ United States
- ARDX United States
- Employees
- BMEZ N/A
- ARDX N/A
- Industry
- BMEZ Trusts Except Educational Religious and Charitable
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- BMEZ Finance
- ARDX Health Care
- Exchange
- BMEZ Nasdaq
- ARDX Nasdaq
- Market Cap
- BMEZ 1.5B
- ARDX 1.3B
- IPO Year
- BMEZ N/A
- ARDX 2014
- Fundamental
- Price
- BMEZ $14.13
- ARDX $3.62
- Analyst Decision
- BMEZ
- ARDX Strong Buy
- Analyst Count
- BMEZ 0
- ARDX 8
- Target Price
- BMEZ N/A
- ARDX $10.19
- AVG Volume (30 Days)
- BMEZ 391.3K
- ARDX 6.3M
- Earning Date
- BMEZ 01-01-0001
- ARDX 05-01-2025
- Dividend Yield
- BMEZ 8.71%
- ARDX N/A
- EPS Growth
- BMEZ N/A
- ARDX N/A
- EPS
- BMEZ 0.54
- ARDX N/A
- Revenue
- BMEZ N/A
- ARDX $361,706,000.00
- Revenue This Year
- BMEZ N/A
- ARDX $15.74
- Revenue Next Year
- BMEZ N/A
- ARDX $34.56
- P/E Ratio
- BMEZ $30.17
- ARDX N/A
- Revenue Growth
- BMEZ N/A
- ARDX 127.33
- 52 Week Low
- BMEZ $12.93
- ARDX $3.62
- 52 Week High
- BMEZ $16.95
- ARDX $9.20
- Technical
- Relative Strength Index (RSI)
- BMEZ 46.37
- ARDX 32.18
- Support Level
- BMEZ $14.06
- ARDX $3.50
- Resistance Level
- BMEZ $14.89
- ARDX $5.65
- Average True Range (ATR)
- BMEZ 0.28
- ARDX 0.30
- MACD
- BMEZ 0.05
- ARDX -0.15
- Stochastic Oscillator
- BMEZ 43.28
- ARDX 5.59
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.